Rising Investments Propelling Expansion in Indian ophthalmoscope Market

2024-04-18 01:34:03 Health and Fitness

858

The growing interest of the investors has propelled in the expansion of Indian ophthalmoscope industry, says RNCOS in its latest report.

According to our report, ?Indian Ophthalmoscope Market Outlook 2022?, the Indian ophthalmoscope industry has witnessed growth in recent years on account of rising population base & increased life expectancy. Also, the increasing number of blind patients particularly due to age-related disorders like cataract is expected to increase, thereby gaining traction and attracting multiple investments in Indian Ophthalmology market. Around US$ 227 Million was invested in the Indian eye care segment upto March 2015.

Top funded players in eye care segment include Vasan Healthcare, Centre for Sight, Eye-Q, ERC Eye Care, PVRI Eye Hospital, Dr. Agarwal?s Eye Hospital and Drishti Eye Care.

For instance, Dr. Agarwal's will be expanding its network in India, Africa, Middle East and Southeast Asia with US$ 45 Million investment by private equity ADV Partners. The company currently owns 60 hospitals and plans to have around 200 hospitals by 2020. Also, the Agarwal?s Group has recently partnered with Dr. Rajeshs Eye Clinic to offer state- of-the-art eye care facility to the residents in and around the locality. The hospital is planning to open around 5 centers across the state and entering Kerala, Gujarat, Odisha and Kolkata.

Acumen Fund?s made an investment of US$ 2 Million in PVRI, through Pushpagiri Health Care Hospitals Pvt. Ltd., to build two additional hospitals, thus expanding its reach to approximately 50% of Andhra Pradesh. Disha Medical Services Pvt Ltd, an eye-care chain focused on providing affordable treatment in underserved markets under the brand Drishti, has also received funding from former Infosys CEO Nandan Nilekani. Maxivision Super Specialty Eye Hospitals, a Chennai-based eyecare chain plans to raise about Rs200 crore, providing an exit to existing investors.

This represents single specialty chains accounting for the major investments as compared to multispecialty hospitals, due to relatively lower operational costs and higher revenue margin which comes from surgeries.

Moreover, the eye-care segment has seen emergence of not-for-profit companies like Aravind Eye Care and Sankara Nethralaya, which provide services at very little cost or free. These two companies have gained both size and critical mass as compared to private companies such as Vasan Eye Care, New Delhi Centre for Sight and Eye-Q.

Most of the investments were focused on aiding the development of new centers. There are a number of initiatives under way that are designed to encourage investment and activity in the ophthalmoscope segment which can bring rapid growth.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM879.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.